The clinical trial of the comparison of Transdiagnostic Therapy with cognitive- behavior therapy on patients with depression and anxiety disorders

The clinical trial of the comparison of Transdiagnostic Therapy with cognitive- behavior therapy on emotion regulation strategies in patients with emotional disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014010516085N1

Enrollment

Registered

2014-03-13

Start date

2012-07-09

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anxiety disorders and depression. generalized anxiety disorder, moderate depressive episode

Interventions

Intervention 1: Treatment in the transdiagnostic condition consisted of 8 weekly 45 minute sessions following unified protocol. The unified protocol consists of five core treatment modules: (a) increa

Barlow, Ellard, et al., 2011). The first session was focused on motivation enhancement for treatment engagement and change. The second session emotional understanding was focused, and the third sessio

Behavior

Treatment in the transdiagnostic condition consisted of 8 weekly 45 minute sessions following unified protocol. The unified protocol consists of five core treatment modules: (a) increasing present-foc

Barlow, Ellard, et al., 2011). The first session was focused on motivation enhancement for treatment engagement and change. The second session emotional understanding was focused, and the third sessi

In the CBT condition, we conducted 8 weekly 45 minute session following cognitive-behavioral diagnosis- specific manuals.

Eligibility

Sex/Gender

All

Age

22 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 18 or older; be fluent in Persian; be able to attend all treatment sessions and assessments; provide informed consent Exclusion criteria: have evidence of dementia or other neuro-cognitive conditions that impair ability; have clinical conditions that require immediate treatment; suicidality; substance use disorders

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Anxiety. Timepoint: at the end of treatment. Method of measurement: by questionnaire.	—

Secondary

Measure	Time frame
Depression. Timepoint: at the end of treatment. Method of measurement: by questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMozhgan Lotfi

Department of Clinical Psychology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

lotfei2007@gmail.com+98 21 2243 9951

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026